Advanced search
Publication Cover
Biomarkers Volume 14, 2009 - Issue 1
Submit an article Journal homepage
73
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty?

Alberto Dominguez-RodriguezDepartment of Cardiology, University Hospital of Canarias, Tenerife, SpainCorrespondence[email protected]
,
Pedro Abreu-GonzalezDepartment of Physiology, University of La Laguna, School of Medicine, Tenerife, Spain
,
Alejandro Jimenez-SosaResearch Unit, University Hospital of Canarias, Tenerife, Spain
,
Sima Samimi-FardDepartment of Cardiology, University Hospital of Canarias, Tenerife, Spain
&
Hernandez-Baldomero IdairaDepartment of Cardiology, University Hospital of Canarias, Tenerife, Spain
Pages 43-48 | Received 31 Oct 2008, Accepted 14 Dec 2008, Published online: 01 Feb 2009

References

  • Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. (2000). The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835–842.
  • Aparci M, Kardesoglu E, Ozmen N, Ozcan O, Cebeci BS, Cingozbay BY, Dincturk M. (2007). Prognostic significance of ischemia-modified albumin in patients with coronary syndrome. Coron Artery Dis 18:367–373.
  • Bar-Or D, Lau E, Winkler JV. (2000). A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia – a preliminary report. J Emerg Med 19:311–315.
  • Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NKR, Curtis CG. (2008). The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387:120–127.
  • Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, Collinson PO, Gaze DC, Kaski JC. (2008). Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemia chest pain. Heart Vessels 23:174–180.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC. (2008). Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta 388:196–199.
  • Dominguez-Rodriguez A, Kaski JC, Abreu-Gonzalez P, Samimi-Fard S. (2008). Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Atherosclerosis doi:10.1016/j.atherosclerosis.2008.07.033.
  • Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. (2004). Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 93:88–90.
  • Killip T, Kimball JT. (1967). Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20:457–464.
  • Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. (2000). TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–2037.
  • Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. (2003). Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92:322–324.
  • Roy D, Quiles J, Gaze DC, Collinson PO, Kaski JC, Baxter GF. (2006). Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113–114.
  • Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. (2004). Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93:366–368.
  • Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. (2003). Ischemia modified albumin is a sensitive marker of ischemia after percutaneous coronary intervention. Circulation 107:2403–2405.
  • Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of ‘ischemia modified albumin’, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34.
  • Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. (2005). Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172:1685–1690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.